ClinicalTrials.Veeva

Menu

Long-Term Follow-up Study to Evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients With Rotator Cuff Disease

Seoul National University logo

Seoul National University

Status

Not yet enrolling

Conditions

Rotator Cuff Disease

Study type

Observational

Funder types

Other

Identifiers

NCT07374679
ASB-LTFUP-001

Details and patient eligibility

About

The purpose of this study is to evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients with Rotator Cuff Disease

Enrollment

21 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects who received the investigational medicinal product in the Phase 1/2a clinical trial (ASB-IP-001).
  • Subjects who voluntarily agreed to participate in this long-term follow-up study and provided written informed consent.

Exclusion criteria

  • Subjects who cannot be contacted by any means, including telephone, mail, or e-mail, and for whom follow-up assessment is therefore not feasible.

  • Subjects deemed inappropriate for participation in this long-term follow-up study at the investigator's discretion, including:

    • Cases in which participation in the study may pose a significant risk to the subject's health or safety; ② Cases in which long-term follow-up visits or assessments are practically impossible due to cognitive impairment, communication difficulties, or similar conditions; ③ Cases in which continued participation in follow-up is unlikely due to difficulty adhering to the study schedule (e.g., prolonged hospitalization, long-term residence abroad).

Trial design

21 participants in 1 patient group

Long-term Follow-up Cohort

Trial contacts and locations

1

Loading...

Central trial contact

KeeJeong Bae, Principal Investigator

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems